Two trials show promising results with gene therapies that target sickle-cell anemia

Two teams of researchers working independently have found success in trialing gene therapies targeting sickle-cell anemia. Both teams have published papers in the New England Journal of Medicine describing their work and results. The first team comprised members from the U.S., Germany, Canada and France; they used the CRISPR-Cas9 gene editing system to boost the […]

Continue Reading